Guru Ownership Trend
Guru Analysis for AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q2 2026, a total of 17 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $3.28 B.
Top institutional holders include Ken Fisher and Cliff Asness.
Notably, Robert Bruce has expressed high conviction in this stock, allocating 8.24% of their equity portfolio to it.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $514 M net inflow during the quarter.
Recent activity highlights Manning & Napier Group who dramatically increased their stake. Conversely, Ray Dalio reduced exposure by 61.2%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q2 2026)
Guru Consensus (Q2 2026)
FAQs for AbbVie Inc. (ABBV)
Major holders include Ken Fisher ($2.39 B), Cliff Asness ($507.11 M), Steven Cohen ($92.31 M). According to the latest reported data, 17 tracked investment managers collectively hold approximately 12.75 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $514 M, with 9 managers increasing positions and 7 managers reducing holdings.
During the most recent reporting period, 6 managers trimmed their positions, while 1 fully exited ABBV. The total reported sell value was $40.81 M.
Yes, 3 managers opened new positions in ABBV, and 6 increased their existing holdings. The total reported buy value was $554.81 M.
